PRESS RELEASE published on 05/13/2025 at 07:45, 1 year 2 months ago Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast Eckert & Ziegler SE reports earnings growth in Q1 2025 with sales of €68.2 million and net income of €9.7 million. Full-year forecast for 2025 confirmed at around €320 million in sales and €78 million in EBIT EBIT Forecast Earnings Growth Sales Forecast Eckert & Ziegler SE Q1 2025
BRIEF published on 04/24/2025 at 14:05, 1 year 3 months ago Eckert & Ziegler Signs Manufacturing Agreement with Pentixapharm Clinical Trials Cancer Therapy Manufacturing Agreement Radiopharmaceuticals Y90-PentixaTher
PRESS RELEASE published on 04/24/2025 at 14:00, 1 year 3 months ago Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm Eckert & Ziegler SE signs manufacturing agreement with Pentixapharm for Y90-PentixaTher, a targeted radiolabeled peptide therapeutic for cancer treatment Manufacturing Agreement Eckert & Ziegler SE Radiopharmaceuticals Pentixapharm Y90-PentixaTher
BRIEF published on 04/11/2025 at 10:35, 1 year 3 months ago Eckert & Ziegler Proposes €0.50 Dividend for FY 2024 Annual General Meeting Dividend Eckert & Ziegler Financial Year 2024 TecDax
PRESS RELEASE published on 04/11/2025 at 10:30, 1 year 3 months ago Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 Eckert & Ziegler SE proposes dividend of €0.50 per share for FY 2024. The Annual General Meeting to be held on June 18, 2025 in Berlin Annual General Meeting Shareholders Dividend Eckert & Ziegler SE FY 2024
BRIEF published on 04/10/2025 at 15:05, 1 year 3 months ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
PRESS RELEASE published on 04/10/2025 at 15:00, 1 year 3 months ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
BRIEF published on 03/27/2025 at 07:50, 1 year 4 months ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE published on 03/27/2025 at 07:45, 1 year 4 months ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 1 year 4 months ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
Published on 07/31/2026 at 08:00, 1 hour 28 minutes ago Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 07/31/2026 at 01:39, 7 hours 49 minutes ago Transition from OTCQB to Unsponsored OTC Quotation
Published on 07/30/2026 at 23:45, 9 hours 43 minutes ago Namibia Critical Metals Announces Completion of Japan's C$23 Million Earn-In and Formation of Strategic Joint Venture Company for the Lofdal Heavy Rare Earth Project
Published on 07/30/2026 at 23:01, 10 hours 27 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended June 30, 2026 and Management Changes
Published on 07/30/2026 at 23:00, 10 hours 28 minutes ago Eagle Plains Announces Approval of Warrant Expiry Extension
Published on 07/31/2026 at 09:00, 28 minutes ago Original-Research: Pentixapharm Holding AG (von NuWays AG): BUY
Published on 07/31/2026 at 08:57, 30 minutes ago FIRST-HALF 2026 RESULTS : Successful launch of the new strategic plan, activity maintained at the very high level of 2025 and solid results
Published on 07/31/2026 at 08:32, 55 minutes ago Completion of the acquisition of the Scholz Recycling Group
Published on 07/31/2026 at 08:21, 1 hour 6 minutes ago Edenred and Abry Partners forge a strategic partnership to support the next phase of Edenred Pay North America’s development
